Dr. Reddy's Laboratories Ltd.NSE: DRREDDY

Press Release Oct 20 2020

· Issued by Dr. Reddy's Laboratories Ltd.

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-oct-20-2020-7

Watch Dr. Reddy's Laboratories' latest callDr. Reddy's Laboratories (NSE:DRREDDY) Q1 2027 Earnings Call · Replay · Jul 22Read the transcript of Dr. Reddy's Laboratories (NSE:DRREDDY) Q1 2027 Earnings Call

Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated October 20, 2020, titled "Dr. Reddy s announces the re-launch of over-the-counter Famotidine Tablets USP, 10 mg and 20 mg, store-brand equivalent of Pepcid AC�� in the U.S. Market".

View Attachment

6ix hasn’t read this filing yet.

Dr. Reddy's Laboratories Ltd. on 6ix

Earlier from Dr. Reddy's Laboratories

Later from Dr. Reddy's Laboratories

All Dr. Reddy's Laboratories news releases